FALLS CHURCH, Va. (PRWEB) September 11, 2019
Radiology… gastroenterology… ophthalmology… pathology…
The AI explosion is revolutionizing image analysis, with many companies developing technologies to evaluate medical images. In fact, image analysis software represents one of the fastest-growing medical device segments.
Unless one understands the approaches the FDA is taking to AI-based image analysis, one will be left behind.
As both a physician and a lawyer, John J. Smith, M.D., J.D, a partner at Hogan Lovells, is uniquely suited to explain what attendees need to know about the FDA’s AI regulation in this 90-minute webinar:
- How FDA views AI within its medical device regulatory paradigm
- The different types of computer-assisted image analysis recognized by FDA
- The data that FDA expects to support AI-based CAD applications
- How FDA views post-market changes to CAD algorithms
Attendees will understand the new regulatory framework the FDA is developing so that one can determine how to best incorporate AI into devices and software.
Interested in registering multiple sites?
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally to learn about our special multisite discount.
Regenerative Medicine and Stem Cell Regulation
What You Need to Know
An FDAnews Webinar
Tuesday, Sept. 17, 2019, 1:30-3:00 p.m. EDT
Tuition: $287 per site
Easy Ways to Register:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.